Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Discover Oncology
Published in:

Open Access 01-12-2024 | Analysis

Causal relationship between immune cells and acute myeloid leukemia: a two-sample Mendelian randomization study

Authors: Fanhua Yu, Hao Jiang, Yena Gu

Published in: Discover Oncology | Issue 1/2024

Login to get access

Abstract

Background

Immune cells are crucial in the etiology of acute myeloid leukemia (AML). Given the genetic, epigenetic, and clonal complexities of AML, pinpointing factors linked to immunotherapy presents a formidable challenge. Moreover, investigations into the connection between immune cells and AML are still in their infancy, necessitating further studies to decode the intricate connections involved.

Materials and methods

Based on Mendelian independent distribution law, Mendelian randomisation (MR) is an analytical method mainly used in epidemiological aetiology inference. This bidirectional two-sample MR study aims to investigate the causal link between immune cell phenotypes and AML. Pooled phenotypic data from 3,757 individuals in a Sardinian cohort, encompassing 731 immune cell phenotypes, were utilized. Aggregate data on AML were sourced from the FinnGen project of the Finnish Biobank. We analyzed the sensitivity of the results and evaluated heterogeneity, employing Cochran’s Q test in conjunction with MR-Egger and MR-Presso to assess pleiotropy levels.

Results

26 distinct immune cell types were identified that potentially linked causally with AML. Furthermore, our analysis indicated a bidirectional causal link between Resting Treg % CD4 Treg, BAFF-R on memory B cells and AML.

Conclusion

This investigation delineates the causal link between immune cell phenotypes and the pathogenesis of AML, thereby unveiling potential therapeutic avenues to modulate immune cell functions in AML patients. It aims to discover innovative therapeutic strategies that target immune evasion tactics to reinstate immune responses against leukemia.
Appendix
Available only for authorised users
Literature
1.
Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–77.CrossRefPubMed
2.
Riva C, Vernarecci C, Minetto P, et al. Harnessing immune response in acute myeloid leukemia. J Clin Med. 2023;12(18):5824.
3.
4.
5.
Bewersdorf JP, Abdel-Wahab O. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic. Genes Dev. 2022;36(5–6):259–77.CrossRefPubMedPubMedCentral
6.
7.
Szczepanski MJ, Szajnik M, Czystowska M, et al. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res. 2009;15(10):3325–32.CrossRefPubMedPubMedCentral
8.
9.
10.
11.
12.
Hansrivijit P, Gale RP, Barrett J, et al. Cellular therapy for acute myeloid Leukemia—current status and future prospects. Blood Rev. 2019;37:100578.CrossRefPubMed
13.
Orrù V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036–45.CrossRefPubMedPubMedCentral
14.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.CrossRefPubMedPubMedCentral
15.
Fei Y, Yu H, Wu Y, et al. The causal relationship between immune cells and ankylosing spondylitis: a bidirectional Mendelian randomization study. Arthritis Res Ther. 2024;26(1):24.CrossRefPubMedPubMedCentral
16.
Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7.
17.
Minelli C, Del Greco MF, Van Der Plaat DA, et al. The use of two-sample methods for Mendelian randomization analyses on single large datasets. Int J Epidemiol. 2021;50(5):1651–9.CrossRefPubMedPubMedCentral
18.
Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.CrossRefPubMedPubMedCentral
19.
20.
Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–55.CrossRefPubMed
21.
Shenghui Z, Yixiang H, Jianbo W, et al. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer. 2011;129(6):1373–81.CrossRefPubMed
22.
23.
Delia M, Carluccio P, Mestice A, et al. Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients. J Immunol Res. 2018;2018:9325261.CrossRefPubMedPubMedCentral
24.
Guo S, Mohan GS, Wang B, et al. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia. J Immunother Cancer. 2024;12(2):e008318.
25.
Rampoldi F, Donato E, Ullrich L, et al. γδ T cells license immature B cells to produce a broad range of polyreactive antibodies. Cell Rep. 2022;39(8):110854.CrossRefPubMed
26.
Freeman AJ, Vervoort SJ, Ramsbottom KM, et al. Natural killer cells suppress T cell-associated tumor immune evasion. Cell Rep. 2019;28(11):2784-94.e5.CrossRefPubMed
27.
Stringaris K, Sekine T, Khoder A, et al. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 2014;99(5):836–47.CrossRefPubMedPubMedCentral
28.
Szczepanski MJ, Szajnik M, Welsh A, et al. Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors. Cancer Immunol Immunother. 2010;59(1):73–9.CrossRefPubMed
29.
Cardillo TM, Govindan SV, Zalath MB, et al. IMMU-140, a novel SN-38 antibody-drug conjugate targeting HLA-DR, mediates dual cytotoxic effects in hematologic cancers and malignant melanoma. Mol Cancer Ther. 2018;17(1):150–60.CrossRefPubMed
30.
Toffalori C, Zito L, Gambacorta V, et al. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat Med. 2019;25(4):603–11.CrossRefPubMed
31.
Tettamanti S, Pievani A, Biondi A, et al. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2022;36(1):13–22.CrossRefPubMed
32.
Sendker S, Reinhardt D, Niktoreh N. Redirecting the immune microenvironment in acute myeloid leukemia. Cancers. 2021;13(6).
Metadata
Title
Causal relationship between immune cells and acute myeloid leukemia: a two-sample Mendelian randomization study
Authors
Fanhua Yu
Hao Jiang
Yena Gu
Publication date
01-12-2024
Publisher
Springer US
Published in
Discover Oncology / Issue 1/2024
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-024-01565-1

Other articles of this Issue 1/2024

Skimmed milk intake reduces the risk of ER− breast cancer: a Mendelian randomization analysis

Knocking down RAD51AP1 enhances chemosensitivity by inhibiting the self-renewal of CD133 positive ovarian cancer stem-like cells

Longitudinal tracking of circulating rare events in the liquid biopsy of stage III–IV non-small cell lung cancer patients

  • Open Access
  • NSCLC
  • Research

Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish immune landscape and efficacy of immunotherapy

Development and validation of a prognostic risk score model for hepatocellular carcinoma in the Asian population based on immunogenic cell death-related genes

BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits